Low dissolution rates of hydrophobic agents limit bioavailability and functional integration in food and pharmaceutical systems. Overcoming this constraint ensures consistent delivery and efficacy of active ingredients.

Inconsistent enzymatic conversion leads to mixtures of alpha, beta, and gamma rings rather than a single purified form. Achieving high specific yields reduces downstream separation costs and material waste.